Tag: Alzheimer’s
Focused Ultrasound May Briefly Open Blood-Brain Barrier
Finding could be a game-changer for the treatment of neurological diseases such as Alzheimer's
Lifetime Risks Temper Biomarker Tests for Alzheimer Dz Dementia
Those younger than 85 years with MCI, amyloidosis, neurodegeneration have risk >50 percent
Women Have Stronger Link Between APOE-ε4, CSF Tau Levels
Sex differences were not seen in the correlation between APOE and neurofibrillary tangle burden
apoE Aggregation May Impact apoE-Mediated Plaque Formation
Anti-human apoE-4 antibody preferentially binds unlipidated aggregated apoE over lipidated version
Nurse Education Improves Post-Op Survival in Dementia Patients
Findings show lower post-surgical mortality among patients with Alzheimer's disease
Concern for Employer, Insurance Discrimination for Alzheimer’s Patients
About half of adults surveyed expect a man with mild Alzheimer's dementia to be discriminated against
Short-Term PPIs Tied to Higher Hip Fracture Risk in Alzheimer’s
No association seen with long-term or cumulative proton pump inhibitor use in Alzheimer's patients
Molecular Markers May ID Alzheimer’s Before Clinical Onset
Amyloid-positive PSEN1 E280A mutation carriers have elevated levels of tau deposition before onset
Pimavanzserin Cuts Alzheimer’s Psychosis at Six Weeks
Significantly greater reduction in NPI-NH psychosis score at 6 weeks versus placebo, but not at 12 weeks
In Alzheimer’s, BACE1 Inhibition May Reverse Amyloid Deposition
Sequential, increased deletion of BACE1 in adult AD mouse model reversed amyloid deposition
